Tag: Sufficiency of disclosure

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Sufficiency of disclosure

Artificial Intelligence (AI) Patents

Added to Collection on: 2019-08-26 23:33:45

Tags for this article:

Creativity
Human behavior
Patent law
Patent
Prior art
Invention
Humans
Patentable subject matter
Inventor
Artificial intelligence in video games
Sufficiency of disclosure
Person having ordinary skill in the art

Click the tags to see associated articles and topics

View Article Details
A Heightened Bar: Federal Circuit Leaves Functional Antibody Claims on Thin Ice

Added to Collection on: 2021-02-26 02:26:15

Tags for this article:

Intellectual property law
Patent law
Medical specialties
Immunology
Patent claim
Antibody
Sufficiency of disclosure
Evolocumab
Monoclonal antibody
Inventive step and non-obviousness
Patent

Click the tags to see associated articles and topics

View Article Details
Patenting Biologics And Other Therapeutics In The United States: Another Strike Against Claims ...

Added to Collection on: 2021-03-15 03:33:45

Tags for this article:

Intellectual property law
Patent law
Sufficiency of disclosure
Patent claim
Patent application
Patent
Enablement
Apotex Inc v Sanofi-Synthelabo Canada Inc
Novelty and non-obviousness in Canadian patent law
United States

Click the tags to see associated articles and topics

View Article Details
Amgen v Sanofi ruling: Its time to kiss goodbye to broad, functional patent claims for antibodies

Added to Collection on: 2021-03-25 14:03:45

Tags for this article:

Life Sciences
Medical specialties
Biotechnology
Biology
Immunology
Antibody
PCSK9
Monoclonal antibody
Sufficiency of disclosure
Biosimilar
Biopharmaceutical
Patent infringement
Kevin O'Connor

Click the tags to see associated articles and topics

View Article Details
Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies

Added to Collection on: 2021-03-25 14:03:45

Tags for this article:

Life Sciences
Medical specialties
Biotechnology
Biology
Immunology
Antibody
PCSK9
Monoclonal antibody
Sufficiency of disclosure
Biosimilar
Biopharmaceutical
Patent infringement
Kevin O'Connor

Click the tags to see associated articles and topics

View Article Details
Artificial Intelligence: Where is Human After All? - Kluwer Patent Blog

Added to Collection on: 2021-03-29 22:42:51

Tags for this article:

Intellectual property law
Patent law
Patent
DABUS
Inventor
Software patent
Person having ordinary skill in the art
Inventive step and non-obviousness
Sufficiency of disclosure
Artificial intelligence
Patentable subject matter
Outline of patents
Yann LeCun

Click the tags to see associated articles and topics

View Article Details
United States: Finding The 'Sweet Spot' Of Enablement In Amgen v. Sanofi: The Federal Circuit ...

Added to Collection on: 2021-04-02 11:26:15

Tags for this article:

Medical specialties
Clinical medicine
Patent law
Monoclonal antibodies
Medicine
PCSK9 inhibitors
Immunology
Sanofi
Evolocumab
PCSK9
Alirocumab
Sufficiency of disclosure
U.S.C.
Amgen
Regeneron

Click the tags to see associated articles and topics

View Article Details
Amgen v. Sanofi: Generally an Attack on Functional Claim Language

Added to Collection on: 2021-04-29 13:41:19

Tags for this article:

Patent law
Companies
Sufficiency of disclosure
Amgen
Sanofi
Enablement
PCSK9
Patent claim
Life Sciences
Health care

Click the tags to see associated articles and topics

View Article Details
United States: Disclosing AI Inventions - Part II: Describing And Enabling AI Inventions

Added to Collection on: 2021-05-04 08:26:15

Tags for this article:

Articles
Academic disciplines
Cognition
Patent law
Sufficiency of disclosure
Software patent
Machine learning
Patent
Artificial neural network
Algorithm
Invention
Title 35 of the United States Code

Click the tags to see associated articles and topics

View Article Details
Patent Poetry: Patent Office Issues Guidelines for Enablement after Amgen | AEON Law

Added to Collection on: 2024-02-06 19:24:12

Tags for this article:

PCSK9
PCSK9 inhibitors
Amgen Inc v. Sanofi
Monoclonal antibodies
Immunology
Low-density lipoprotein
Enablement
United States patent law
Sanofi
Sufficiency of disclosure
Utility
Antibody
Amgen Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo